Sylvia K. Plevritis, PhD
Publication Details
-
Online tool to guide decisions for BRCA1/2 mutation carriers.
J Clin Oncol. 2012; (5): 497-506
Women with BRCA1 or BRCA2 (BRCA1/2) mutations must choose between prophylactic surgeries and screening to manage their high risks of breast and ovarian cancer, comparing options in terms of cancer incidence, survival, and quality of life. A clinical decision tool could guide these complex choices.
Help
Trial Administration